We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Generation Bio Co (GBIO) USD0.0001

Sell:$5.37 Buy:$5.43 Change: $0.40 (6.97%)
NASDAQ:2.18%
Market closed |  Prices as at close on 6 February 2026 | Switch to live prices |
Takeover

Generation Bio Co USD0.0001

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 29 Jan 2026)

The boards of Generation Bio Co, XOMA Royalty Corporation and XRA 7 Corp have announced the terms of a takeover offer. Under the terms of the takeover, you have been offered USD4.2913 and 1 new Contingent Value Right (CVR) for each share held.

 

The CVR represents the right to receive certain potential payments in cash depending on the achievement of certain milestones. Please note that there is no guarantee that the CVRs will generate any further payments. Further information regarding the terms of the CVRs can be found at https://investors.generationbio.com/news-events/news-releases.

If you don’t want to sell any shares, you don’t need to do anything. Depending on the level of acceptance the offeror may choose to delist or compulsorily acquire the remaining shares at a later date.

Accept the offer – Act by noon on Wednesday 4 February 2026

Any shares you ask to sell will be removed from your portfolio from 4 February 2026. Any shares not successfully sold will be returned to your account around the same time.

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the message and not on the summary information outlined above.

×
Sell:$5.37
Buy:$5.43
Change: $0.40 (6.97%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 6 February 2026 | Switch to live prices |
Takeover

Generation Bio Co USD0.0001

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 29 Jan 2026)

The boards of Generation Bio Co, XOMA Royalty Corporation and XRA 7 Corp have announced the terms of a takeover offer. Under the terms of the takeover, you have been offered USD4.2913 and 1 new Contingent Value Right (CVR) for each share held.

 

The CVR represents the right to receive certain potential payments in cash depending on the achievement of certain milestones. Please note that there is no guarantee that the CVRs will generate any further payments. Further information regarding the terms of the CVRs can be found at https://investors.generationbio.com/news-events/news-releases.

If you don’t want to sell any shares, you don’t need to do anything. Depending on the level of acceptance the offeror may choose to delist or compulsorily acquire the remaining shares at a later date.

Accept the offer – Act by noon on Wednesday 4 February 2026

Any shares you ask to sell will be removed from your portfolio from 4 February 2026. Any shares not successfully sold will be returned to your account around the same time.

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the message and not on the summary information outlined above.

×
Sell:$5.37
Buy:$5.43
Change: $0.40 (6.97%)
Market closed |  Prices as at close on 6 February 2026 | Switch to live prices |
Takeover

Generation Bio Co USD0.0001

Type:
Takeover
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 29 Jan 2026)

The boards of Generation Bio Co, XOMA Royalty Corporation and XRA 7 Corp have announced the terms of a takeover offer. Under the terms of the takeover, you have been offered USD4.2913 and 1 new Contingent Value Right (CVR) for each share held.

 

The CVR represents the right to receive certain potential payments in cash depending on the achievement of certain milestones. Please note that there is no guarantee that the CVRs will generate any further payments. Further information regarding the terms of the CVRs can be found at https://investors.generationbio.com/news-events/news-releases.

If you don’t want to sell any shares, you don’t need to do anything. Depending on the level of acceptance the offeror may choose to delist or compulsorily acquire the remaining shares at a later date.

Accept the offer – Act by noon on Wednesday 4 February 2026

Any shares you ask to sell will be removed from your portfolio from 4 February 2026. Any shares not successfully sold will be returned to your account around the same time.

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the message and not on the summary information outlined above.

×
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
$5.70
Trade high:
$5.70
Year high:
$8.40
Market capitalisation
Market cap.
:
$37.87 million
Previous close:
$5.74
Trade low:
$5.34
Year low:
$3.00
Shares in issue
Shares
:
6.74 m
Previous:
$0.12 (2.14%) Previous:
$0.12
Volume:
n/a
Dividend yield:
0.00%
Currency:
USD
Data delayed by at least 15 minutes.
* To buy US shares you must first complete and return a US government ‘W-8BEN’ form.

Share chart Chart

GENERATION BIO ORD performance chart

Ready to invest?

Invest now

Want to invest?

To buy shares in , you'll need to have an account.

Explore the options

Important Documents

There are no documents available for this stock.

Dividend information for this stock is not available.

Dividend information for this stock is not available.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by Reuters. Charts provided by Factset. News and fundamental data provided by Digital Look. Exchange disclaimer
Thomson Reuters Logo

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.